RE: Skinbiotherapeutics shares13 Jul 2018 15:17
SOH is committed to the SBTX in-specie at some point in the future. When? Nobody knows, but logic suggests post passing human trials, which are expected to be confirmed at some point in October. If, as we all hope, if not expect, they are good, this greatly increased the value of the IP and of course put the company is a very strong position when they have potential partners sat around the table.
The divi will be stage managed around these events, because there would be a very good expectation of a re-rate in the shares. However, SOH has a trick to pull off by distributing the divi without dragging SBTX shares back down again. The only way I can this being pulled off, if by way of a cash divi, instead of SBTX shares. To do this OPTI would need to sell part of all of their 42% into save hands, like II with an assurance they don't flip.
IMHO, you could sell your OPTI shares now and buy them back in an ISA and still qualify for the divi....its retrospective, so you should be safe. This way you wrap your divi and your OPTI in the ISA.
Seek appropriate advice.